Atomwise Pitch Deck used to Raise $123 Million in Series B Funding

 

Atomwise Background

Atomwise claims its AtomNet platform can screen 16 billion chemical compounds for potential hits in under two days, expediting a process that would normally take months or years.

AtomNet’s AI algorithms screen for things like potency and the degree to which a drug acts on a given site while guarding against toxicity, and they work on targets in hard-to-reach parts of the body — like the central nervous system — with a hit rate the company claims is 10,000 times better than wet-lab experiments.

About the Atomwise Pitch Deck

• Raised: $123M
• Year: 2020
• Stage: Series B
• Industry: Healthcare
• Tags: NA
• Business Model: NA
• Customer Model: B2B

Atomwise from PPerksi